Duffy MJ - Search Results

1

High levels of cathepsin B predict poor outcome in patients with breast cancer.

Maguire TM, Shering SG, Duggan CM, McDermott EW, O'Higgins NJ, Duffy MJ. Maguire TM, et al. Among authors: duffy mj. Int J Biol Markers. 1998 Jul-Sep;13(3):139-44. doi: 10.1177/172460089801300303. Int J Biol Markers. 1998. PMID: 10079387

2

Measurement of erbB-2 oncoprotein in human breast cancers by ELISA.

Nugent A, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ. Nugent A, et al. Among authors: duffy mj. Biochem Soc Trans. 1992 Feb;20(1):82S. doi: 10.1042/bst020082s. Biochem Soc Trans. 1992. PMID: 1353039 No abstract available.

3

Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer.

Nugent A, McDermott E, Duffy K, O'Higgins N, Fennelly JJ, Duffy MJ. Nugent A, et al. Among authors: duffy k, duffy mj. Clin Chem. 1992 Aug;38(8 Pt 1):1471-4. Clin Chem. 1992. PMID: 1353709

4

Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival.

Duffy MJ, Reilly D, Brouillet JP, McDermott EW, Faul C, O'Higgins N, Fennelly JJ, Maudelonde T, Rochefort H. Duffy MJ, et al. Clin Chem. 1992 Oct;38(10):2114-6. Clin Chem. 1992. PMID: 1395002

5

CA 15-3 in patients with locoregional and metastatic breast carcinoma.

Geraghty JG, Coveney EC, Sherry F, O'Higgins NJ, Duffy MJ. Geraghty JG, et al. Among authors: duffy mj. Cancer. 1992 Dec 15;70(12):2831-4. doi: 10.1002/1097-0142(19921215)70:12<2831::aid-cncr2820701218>3.0.co;2-8. Cancer. 1992. PMID: 1451063

6

Urokinase-plasminogen activator in breast cancer: assay by both catalytic and immunoassay.

Reilly D, Andreasen PA, Duffy MJ. Reilly D, et al. Among authors: duffy mj. Blood Coagul Fibrinolysis. 1991 Feb;2(1):47-50. Blood Coagul Fibrinolysis. 1991. PMID: 1772998

7

Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings.

Duffy MJ, Brouillet JP, Reilly D, McDermott E, O'Higgins N, Fennelly JJ, Maudelonde T, Rochefort H. Duffy MJ, et al. Clin Chem. 1991 Jan;37(1):101-4. Clin Chem. 1991. PMID: 1899058

8

Urokinase plasminogen activator and prognosis in breast cancer.

Duffy MJ, Reilly D, O'Sullivan C, O'Higgins N, Fennelly JJ. Duffy MJ, et al. Lancet. 1990 Jan 13;335(8681):108. doi: 10.1016/0140-6736(90)90571-l. Lancet. 1990. PMID: 1967386 No abstract available.

9

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.

Duffy MJ, Reilly D, O'Sullivan C, O'Higgins N, Fennelly JJ, Andreasen P. Duffy MJ, et al. Cancer Res. 1990 Nov 1;50(21):6827-9. Cancer Res. 1990. PMID: 2119883

10

Plasminogen activators and cancer.

Duffy MJ. Duffy MJ. Blood Coagul Fibrinolysis. 1990 Dec;1(6):681-7. Blood Coagul Fibrinolysis. 1990. PMID: 2133247 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters